Cargando…
Management of osteoporosis and menopausal symptoms: focus on bazedoxifene/conjugated estrogen combination
Loss of estrogen production in women during menopause results in a state of estrogen deficiency which has been associated with multiple problems, including vasomotor symptoms, symptoms of vulvovaginal atrophy, bone loss, and difficulties with sleep, mood, memory, and sexual activity. The only treatm...
Autores principales: | Mirkin, Sebastian, Pickar, James H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3743641/ https://www.ncbi.nlm.nih.gov/pubmed/23966802 http://dx.doi.org/10.2147/IJWH.S39455 |
Ejemplares similares
-
Patient considerations in the management of menopausal symptoms: role of conjugated estrogens with bazedoxifene
por: Kagan, Risa, et al.
Publicado: (2016) -
Incorporating bazedoxifene/conjugated estrogens into the current paradigm of menopausal therapy
por: Komm, Barry S, et al.
Publicado: (2012) -
The Tissue-Selective Estrogen Complex (Bazedoxifene/Conjugated Estrogens) for the Treatment of Menopause
por: Lello, Stefano, et al.
Publicado: (2017) -
Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fracture
por: Rossini, Maurizio, et al.
Publicado: (2013) -
Conjugated Estrogens and Bazedoxifene Improve β Cell Function in Obese Menopausal Women
por: Lovre, Dragana, et al.
Publicado: (2019)